Skip to main content

Site notifications

AusPAR: Xeomin

Australian Public Assessment Report
Device/Product Name
Xeomin
Active ingredients
incobotulinumtoxinA
AusPAR Date
Published
Submission Number
PM-2022-03519-1-1
Submission Type
Extension of indication
Decision
Approved

Help us improve the Therapeutic Goods Administration site